5 rounds, about $364M in disclosed capital. The biggest was Oxford spin-out OMass Therapeutics at $297M, with Jefferson Life Sciences named as investors.
Every round logged
| Company | Amount | Round | Investors | Sector | Reported by |
|---|---|---|---|---|---|
| Oxford spin-out OMass Therapeutics | €275 million | Series C | Jefferson Life Sciences | Health | EU-Startups |
| LearnUpon | €44.5 million | — | Claret Capital Partners | AI agents | EU-Startups |
| Goodweek | €10.69 million | Seed | Spanish venture capital firm Adara Ventures | AI | EU-Startups |
| Norwegian open banking provider Neonomics | €3.56 million | — | — | Fintech | EU-Startups |
| Unravel Health | €2.96 million | — | Conduit EIS Impact Fund, Wrightwood, Embryo Ventures | Health | EU-Startups |
How this list is built
Rounds come from public funding announcements and the outlets credited in the last column. Amounts are as reported; non-dollar amounts are shown in their original currency. Nothing is estimated.
See the full, searchable record on the AI funding tracker. Spotted an error or a missing round? Tell us via corrections.